CAS: 666842-36-0 - 3-[[3-[4-[[3-(β-D-Glucopyranosyloxy)-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-3-methylphenoxy]propyl]amino]propanamide

Formel: C₂₆H₄₀N₄O₈

InChl: InChI=1S/C26H40N4O8/c1-14(2)21-18(25(30-29-21)38-26-24(35)23(34)22(33)19(13-31)37-26)12-16-5-6-17(11-15(16)3)36-10-4-8-28-9-7-20(27)32/h5-6,11,14,19,22-24,26,28,31,33-35H,4,7-10,12-13H2,1-3H3,(H2,27,32)(H,29,30)/t19-,22-,23+,24-,26+/m1/s1

InChI Key: InChIKey=MDBARDSTXONTFS-MNDUUMEHSA-N

SMILES: O=C(N)CCNCCCOC1=CC=C(C(=C1)C)CC=2C(=NNC2C(C)C)OC3OC(CO)C(O)C(O)C3O

Synonyme:

• 3-[[3-[4-[[3-(β-D-Glucopyranosyloxy)-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-3-methylphenoxy]propyl]amino]propanamide
• Propanamide, 3-[[3-[4-[[3-(β-D-glucopyranosyloxy)-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-3-methylphenoxy]propyl]amino]-
• KGA 2727

KGA-2727

CAS: 666842-36-0

KGA-2727: potent, selective SGLT1 inhibitor (human Ki 97.4 nM, rat 43.5 nM), with high selectivity …

• Formel: C₂₆H₄₀N₄O₈
• Reinheit: 98.95%
• Farbe und Form: Solid
• Molekulargewicht: 536.62

KGA-2727

CAS: 666842-36-0

KGA-2727 is a novel, orally administered, non-peptidic, small molecule antidiabetic agent that increases glucose uptake …

• Formel: C₂₆H₄₀N₄O₈
• Reinheit: Min. 95%
• Molekulargewicht: 536.6 g/mol